Tessera

Ahir vam tenir el plaer de gaudir de la #BBQ2026 de Catalonia.health! 🔥Una vesprada per retrobar-nos i crear noves connexions en un entorn distès i agradable. Ens veiem a la propera edició! #CataloniaHealth #Salut #Networking #CreatioUB @ub.edu @ubneuro.bsky.social sky.social @idibaps.bsky.social

Nuestro Director, Josep M. Canals, participará en RICORS/TERAV+ 2026 como moderador del Foro de Discusión "Presente y futuro de la Manufactura Académica". - Jueves 8 de julio, 18:00–18:30 ¡No te lo pierdas! @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

Today at @fens.org 2026, Marta Cervera Sospedra will be sharing her work on the development of human stem cell-based models for assessing neurodevelopmental toxicity. 🔹 PS04-08PM-140 (14:00–17:30) ¡Visit our poster to learn more about our research! @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

Already at #FENS2026? Don't miss our posters! The Creatio UB team is presenting three posters showcasing our latest research in neuroscience, neurodegeneration, and ageing. If you're attending, come by our posters, say hello and let's talk science! @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

🧠 See you at Federation of European Neuroscience Societies - FENS 2026! The Creatio UB team is excited to take part in #FENS2026, one of Europe's leading neuroscience congresses that brings together researchers to share the latest advances. @ub.edu @idibaps.bsky.social @ubneuro.bsky.social

¡Nos vemos en TERAV+ 2026! La semana que viene, el equipo de Creatio UB participará en la 20ª edición del curso Terapias Avanzadas: 🔹 Prof. @canals-creatio.bsky.social 🔹Dr. Unai Perpiñà, Responsable Tècnico Veremos avances científicos, clínicos, regulatorios y de producción de ATMP. #TERAV+ #ATMP

📢 Don’t miss Poster 141 at #ESTIV2026! Today, Marta Cervera presents Creatio UB’s work on hPSC-derived models for developmental neurotoxicity testing. Looking forward to engaging with the community! #NAMs #BrainOnChip #DNT #TERAV+ #IV4HD @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

Creatio is on site @ #ESTIV2026! Prof. Josep M. Canals and Marta Cervera join the in vitro toxicology community to follow NAMs advances, share our work, and explore collaborations. We look forward to an inspiring congress! #NAMs #TERAV #IV4HD @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

Creatio will be at #ESTIV2026 in Maastricht! Prof. Josep M. Canals and Marta Cervera will attend and present Poster 141 on hPSC-derived monolayer and BoC models for developmental neurotoxicity testing (30/06) . 🤝 See you there! #NAMs #TERAV+ #IV4HD @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

⬆️ NAMs are shaping the future of toxicology and biomed research. At Creatio, we contribute to this transition through human-based models for neurotoxicity, neurodevelopment, brain-on-chip and Huntington’s disease research. 📍 See you at #ESTIV2026! #NAMs #3Rs #InVitroToxicology #BrainOnChip #IV4HD

📢 Open #PredoctoralResearcher position at Creatio! The PhD position is part of the #MSCA #VISI-ON-BRAIN Doctoral Network focused on human in vitro models for neuroscience under Prof. Josep M. Canals. 📅 Deadline: 18/06/26 📍BCN 👉 Apply: link in bio @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

Creatio at the #LUMINATEproject meeting in Leuven. BE. Prof. Josep M. Canals joined the consortium to review 18-month progress and next steps towards clinical translation of the in situ #bioprinted #ATMPs therapy for osteochondral lesions. @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

📢 Creatio has joined the EIC ecosystem Partnership Programme as #EICPartner and is now listed in the EIC Service Catalogue. We look forward to supporting EIC-funded innovators with non-clinical services #EIC #BiomedicalInnovation @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

A very enriching day! We thanks @www.pcb.ub.edu for their support and to everyone who attended. Your participation made the session valuable for us. At Creatio, we´re committed to supporting ATMP projects and helping move them to the clinic. @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

📢 L’equip de Creatio assistirà el 3 i 4 de juny al XIV Simposi de Neurobiologia de la @scb.iec.cat. Hi presentarem 2 comunicacions orals sobre models hPSC per a neurotoxicitat i Terapia GMP per a Huntington. #Neurociència #NAMs #TeràpiesAvançades @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

📣 Last call for tomorrow’s session on technical and requirements on ATMP development. You'll also have the chance to discover Creatio first-hand! 2 June | 9:30 am | PCB ⏳ 1 day to go; Registration link in comments #ATMP #GMP #GLP @ub.edu @ubneuro.bsky.social @idibaps.bsky.social @www.pcb.ub.edu

Every product has a #roadmap, #ATMPs too. At Creatio, we support developers along the journey. Meet our team on 2 June at @www.pcb.ub.edu 📢 Technical and Legal Requirements for ATMP Development ⏳ Less than 1 week to go! 👉 Registration link in bio. @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

In #ATMP development, #GLP & #GMP matter earlier than many developers think. GLP supports credible preclinical safety data. GMP supports consistent manufacturing for the clinic. We’ll go deeper on 2 June @www.pcb.ub.edu 👉 Registration link in bio. @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

From Bratislava, Prof. Josep M. Canals, Director of Creatio UB, is joining the #ERAAction on #NAMs meeting, a European initiative advancing more predictive, ethical and sustainable NAM for biomedical and regulatory science. #3Rs #RegulatoryScience @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

La #FestadelaCiènciaUB ha estat molt enriquidora! 🙌 Hem apropat la #bioimpressió3D als joves, mostrant com permet crear models cel·lulars per estudiar malalties i noves teràpies. Gràcies visitants! #Recerca @ub.edu @ubneuro.bsky.social y.social @idibaps.bsky.social baps.bsky.social

ATMPs face a long path to patients 🔹 90–95% drugs are not approved 🔹 14.5% Success rate 🔹 59% ATMP MA Technical and legal knowledge helps build a path to the clinic. 2 June @www.pcb.ub.edu. Training session 👉 Registration in bio @unibarcelonathe.bsky.social @ubneuro.bsky.social @idibaps.bsky.social

📢 CREATIO estará a la #FestadelaCiènciaUB amb un taller de #bioimpressió3D, una tecnología innovadora per recerca i desenvolupament de noves aproximacions terapèutiques. 📍 Edifici Històric de la UB 📅 15/05/2026 | 9–14 h #Recerca #Divulgació @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

📢 We are pleased to welcome Álvaro Murillo and Laia Rivas to the team! Álvaro joins as a postdoc in #genetherapy within RICORS/TERAV+. Laia joins as a predoctoral researcher developing a #celltherapy for Huntington’s disease. Welcome to the team! @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

🚧Bringing ATMPs closer to patients requires more than strong science. It also means understanding technical and regulatory framework. 👉 Join us for our upcoming training session. Registration is now open @ub.edu @medicinacs-ub.bsky.social @idibaps.bsky.social

💜 Aquest mes de maig la Facultat de Medicina i Ciències de la Salut - @ub.edu es suma a #LightItUp4HD2026, la campanya internacional de conscienciació sobre la Malaltia de Huntington #Huntington #ACMAH #FEPAEH @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

La jornada ha començat ben activa al Clínic Obert! 🙌 L’equip de Creatio UB és a la carpa per compartir què fem i com la recerca pot arribar a transformar la salut. #ClínicObert #DivulgacióCientífica @ub.edu @ubneuro.bsky.social @idibaps.bsky.social

🚀 Registration is open: Technical and Legal Requirements for ATMP Development Training Session 📅 2 June 2026 | 9:30 am 📍 Parc Científic de Barcelona 👉 Register bit.ly/ATMPsession #ATMP #RegulatoryStrategy #ClinicalTranslation @ub.edu @ubneuro.bsky.social @idibaps.bsky.social @www.pcb.ub.edu

In 2025, Creatio strengthened its role as leading academic center translating biomed innovation into clinical applications 📌2025 highlights: • 13 funded projects • 29 on-demand RDI projects • 19 manufacturing activities 👉https://bit.ly/2026_Report @ub.edu @ubneuro.bsky.social @idibaps.bsky.social